Fibroblasts turn into cancer associated fibroblasts (CAFs) in the tumour microenvironment. CAFs have recently attracted attention for their function as a regulator of immune cell recruitment and function in addition to their tumour-promoting roles. In this study, we aimed to determine the role of CAFs on monocyte recruitment and macrophage polarization in breast cancer. CAFs, which were α-SMA expressing fibroblasts in contrast to normal fibroblasts (NFs), effectively recruited monocytes. Recruitment of monocytes by CAFs might be mediated by monocyte chemotactic protein-1 (MCP-1) as well as stromal cell-derived factor-1 (SDF-1) cytokines. CAFs differentiated the recruited monocytes into M2-like macrophages which are capable of exerting their immunosuppressive roles via the PD-1 axis. CAF-educated monocytes exhibited strong immune suppression unlike NF-educated monocytes and enhanced the motility/invasion of breast cancer cells in addition to increasing the expressions of epithelial–mesenchymal transition (EMT)-related genes and vimentin protein in cancer cells. CAF-educated M1 macrophages displayed increased expression of M2 markers and production of anti-inflammatory cytokine IL-10 in contrast to decreased production of pro-inflammatory cytokine IL-12 compared with control M1 macrophages; suggesting that CAFs were also able to induce the trans-differentiation of M1 macrophages to M2 macrophages. We then investigated the relationship between the infiltration of CAFs and tumour associated macrophages (TAMs) using tissue samples obtained from breast cancer patients. High grade of CAFs significantly correlated with the number of TAMs in human breast cancer tissue samples. It was also associated with higher Ki-67 proliferation index, and higher tumour volume. This result is in line with our finding of increased breast cancer cell proliferation due to the effects of CAF-educated monocytes in vitro. Our results concluded that CAFs play pivotal roles in sculpturing the tumour microenvironment in breast cancer, and therapeutic strategies to reverse the CAF-mediated immunosuppressive microenvironment should be taken into consideration.
Tumours of epithelial origin grow in a complex and dynamic stroma consisting of stromal cells, immune cells, matrix proteins and soluble factors. This microenvironment provides all the necessary stimuli for tumour survival, growth, and invasiveness. Inflammatory cells and the pro-inflammatory cytokines they produce are essential components of this microenvironment1.
Monocytes originating from blood differentiate into either M1 or M2 subtype macrophages, depending on the environmental stimuli they receive2,3. Human M1 macrophages demonstrate elevated expressions of CD14, CD16, CD64, CD86, and Human Leukocyte Antigen (HLA)-DRα3,4; whereas, CD163 and CD206 are markers associated with M2 macrophages5,6. In breast cancer, macrophages represent up to 50% of the tumour mass7 and there exists a correlation between the number of tumour associated macrophages (TAMs) and poor prognosis8. Macrophages have roles in almost all stages of tumour progression9. In the primary tumour, they stimulate angiogenesis and facilitate invasion. During metastasis, macrophages prepare the pre-metastatic site and promote tumour cell dissemination as well as growth. They also generate an immunosuppressive microenvironment by disrupting natural killer (NK) and T cell functions9. TAMs usually resemble M2 macrophages10. During tumour development, tumour-infiltrating M1-polarized macrophages are generally identified by an IL-12high IL-10low phenotype and they enhance immune reactions that display anti-tumour effects. During late-stages of tumour progression, TAMs generally skew to an M2-like phenotype that is characterized by an IL-12low IL-10high phenotype and diminished tumouricidal activity11. The identification of molecules driving macrophage plasticity in the cancer microenvironment could provide a basis for macrophage-focused diagnostic and therapeutic strategies12.
Fibroblasts are one of the most abundant cell types found in the tumour stroma. Fibroblasts turn into cancer associated fibroblasts (CAFs) in the tumour microenvironment. As tumours are described as “wounds that never heal”13, CAFs are very similar to myofibroblasts, which are spindle shaped activated fibroblasts14. Although there is no specific marker that is exclusively expressed by CAFs, alpha smooth muscle actin (α-SMA) is widely used as a CAF marker15. CAFs not only play an active role in tumour initiation and progression, but also sculpt the tumour microenvironment16,17. CAFs have recently attracted attention for their function as regulators of immune cell recruitment as well as functions. Studies in breast cancer investigating the effects of stromal fibroblasts on monocytes/macrophages are very limited. In this study, we report for the first time that CAFs obtained from invasive breast cancer differentiated monocytes to M2-like pro-tumoural macrophages in terms of both phenotypic features and functions, in contrast to fibroblasts obtained from normal breast. We also demonstrated that CAFs were very effective in recruiting monocytes. Monocyte chemotactic protein-1 (MCP-1) and stromal cell-derived factor-1 (SDF-1) were found to be crucial monocyte chemotactic cytokines that were secreted from stromal cells.
CAFs, which are α-SMA expressing fibroblasts in contrast to NFs, effectively recruit monocytes
CAFs were isolated from breast cancer tissues obtained from patients undergoing mastectomy. As healthy counterparts, we used normal fibroblasts (NFs) isolated from normal breast tissues obtained from patients undergoing reduction mammoplasty. Primary cultures of both of those isolated fibroblasts were established. All fibroblasts utilized in the experiments were characterized by vimentin, pan-cytokeratin and α-SMA expressions by immunocytochemistry. They differed in their expressions of α-SMA, which was consistently negative in NFs (n = 3) and positive in CAFs (n = 4). Representative figures of NFs and CAFs are shown in Fig. 1.
In order to evaluate the effects of CAFs and breast cancer cells on monocyte recruitment, we performed cell migration assays. Monocytes were isolated from peripheral blood of healthy humans. Conditioned mediums (CMs) collected from CAFs, NFs, and breast cancer cells were used in a Boyden migration assay, in which monocytes migrate toward CM in the bottom chamber. Our results demonstrated that CAFs as well as breast cancer cells recruited monocytes effectively (Fig. 2A,B).
Recruitment of monocytes by CAFs might be mediated by MCP-1 as well as SDF-1 cytokines
In order to investigate the molecular mechanisms underlying monocyte recruitment by CAFs, we focused on MCP-1 and SDF-1 cytokines. Our results showed that inhibiting MCP-1 or SDF-1 activity through MCP-1 or CXCR4 (a chemokine receptor specific for SDF-1) blocking antibodies, respectively, reduced monocyte migration, significantly. Although both SDF-1 and MCP-1 are relevant for monocyte recruitment mediated by both CAF and breast cancer cells; SDF-1 seems to be more important for CAF-induced monocyte recruitment, while MCP-1 is more prominent for breast cancer cell mediated monocyte migration (Fig. 2B).
CAFs induce a pro-tumoural phenotype, which resembles M2 macrophages like TAMs, in monocytes/macrophages in contrast to NFs
We established an in vitro model utilizing CD14+ cells isolated from healthy donors and CMs obtained from CAFs, NFs, and breast cancer cells in order to investigate the effects of the tumour stromal cells as well as the tumour cells on monocyte differentiation. Following 7 days of culture, the expressions of CD163 and CD206, which are mostly associated with M2 macrophages, were higher in CAF-educated cells than in NF-educated cells. In addition, the expression of programmed cell death protein 1 (PD-1) was higher in CAF-educated cells than in NF-educated cells. In fact, NF-educated cells’ expressions of PD-1, CD163 and CD206 were similar to control monocytes. On the other hand, the expression of CD14 was much higher in NF-educated cells than in CAF-educated cells. In addition, major histocompatibility complex (MHC) class II (HLA-DR) expression of CAF-educated cells is much lower than that of NF-educated cells as well as breast cancer cell-educated monocytes. The expressions of CD86 were comparable between the groups (Fig. 3).
CAF-educated monocytes exhibit strong immunosuppression
We investigated whether CAF-educated monocytes could inhibit T-cell proliferation. For this purpose, human autologous CD4+ peripheral T lymphocytes stimulated with anti-CD3/CD28 magnetic beads were co-cultured with control monocytes, NF-, or CAF-educated monocytes. As shown in Fig. 4, CAF-educated monocytes markedly suppressed T-cell proliferation in effector-cell-to-target-cell-ratio (E:T) dependent manner; since a higher E:T seems to result in a more prominent immunosuppression (Fig. 4B).
CAF-educated monocytes enhance the motility of breast cancer cells
In order to investigate the effects of CAF-educated monocytes on the motility of breast cancer cells, we treated MDA-MB-231 breast cancer cells with CMs from CAF-, NF-, or MDA-MB-231- educated monocytes. The invasion of breast cancer cells was enhanced by the effects of CAF-educated monocytes (similar to MDA-MB-231-educated monocytes), whereas the invasion of breast cancer cells was not significantly changed by the effects of NF-educated monocytes, compared to that of control monocytes (Fig. 5). In addition, we investigated the changes in expressions of EMT-related proteins of MDA-MB-231 breast cancer cells due to the effects of CAF-educated monocytes. For this reason, we treated MDA-MB-231 cells with CMs from CAF-, NF-, or MDA-MB-231- educated monocytes. Vimentin expression was found to be increased and E-cadherin expression was found to be decreased in breast cancer cells by the effects of CAF-educated monocytes. On the contrary, neither vimentin nor E-cadherin expression was significantly changed by the effects of NF-educated monocytes, compared to that of control monocytes (Fig. 6A–D). Real-time qPCR results showed that CAF-educated monocytes induce breast cancer cell expressions of Snail, Slug and Twist genes; which are EMT-related genes, both compared with control monocytes and with NF-educated monocytes (Fig. 6E–G).
CAFs re-direct differentiated M1 macrophages to M2-like macrophages
We then set out to explore whether CAFs were able to induce the differentiation of M1 macrophages to M2 macrophages. For this reason, we cultured M1 macrophages with CMs of CAFs as well as breast cancer cells. After 2 days, the expression of CD163 significantly increased in M1 macrophages treated with CMs of either CAFs or MDA-MB-231 breast cancer cells; as a result, resembling the surface expression of M2 macrophages (Fig. 7). Even though CD206 expressions of CAF- or breast cancer cell-educated M1 macrophages slightly increased, such increases were not found to be statistically significant (Fig. 7B); whereas, CD206 expression of CAF-educated monocytes was shown to increase significantly (Fig. 3B). In addition, we determined IL-10 and IL-12 cytokine levels in culture supernatants. IL-12 cytokine levels decreased in the supernatants of both CAF- and breast cancer cell-educated M1 macrophages. On the other hand, IL-10 cytokine levels seem to have slightly increased in the supernatants of both CAF- and breast cancer cell-educated M1 macrophages, although this increase was not found to be statistically significant (Fig. 7C).
High grade of CAFs significantly correlated with the number of TAMs in breast cancer tissue samples
We analysed the presence of macrophages positive for CD163 and CD206 as well as α-SMA positive fibroblasts in 50 human breast cancer samples using immunohistochemistry. We divided the sample group into high and low grade groups based on the median number of CD163+ macrophages (64; range 18−151), and CD206+ macrophages (15; range 2–50). We then analysed the associations of TAM grade with clinical and pathological features (Table 1). High level of infiltration of stromal CD163+ macrophages was associated with higher histologic grade, higher Ki-67 proliferation index, and higher tumour volume. High CAF grade was also associated with higher Ki-67 proliferation index, and higher tumour volume (Table 1).
As macrophages were observed to reside in the vicinity of α-SMA+ CAFs in the tissue samples (Fig. 8), we then investigated the association between the grade of TAMs and the grade of CAFs in the breast cancer tissues. Indeed, we found that high grade CAF tissues harboured higher numbers of CD163+ or CD206+ macrophages (Fig. 8A–D and Table 2). In addition, low CAF grade was associated with lower numbers of CD163+or CD206+ macrophages (Fig. 8I–L, Table 2).
CAF-educated monocytes increased the proliferation of breast cancer cells
In order to investigate the effects of CAF-educated monocytes on breast cancer cell proliferation in vitro, we treated MDA-MB-231 breast cancer cells with CMs from CAF- or NF- educated monocytes. CAF-educated monocytes increased the proliferation of breast cancer cells. On the other hand, the proliferation of breast cancer cells was not significantly changed by the effects of NF-educated monocytes, compared to that of MDA-MB-231- educated monocytes (Fig. 9A). Similar findings concerning the effects of NF- and CAF- educated monocytes on breast cancer cell proliferation were observed in real-time and label-free analysis of MDA-MB-231 cells with the xCELLigence system (Fig. 9B).
It is now clear that there is a continual crosstalk not only between tumour cells and immune cells but also between stromal cells such as CAFs and immune cells. This crosstalk has an important role on development and progression of tumours. CAFs have recently been implicated in regulation of immune cell recruitment and function. In this study, we aimed to determine the role of cancer associated fibroblasts, compared with normal fibroblasts and breast cancer cells, on monocyte recruitment and polarization in breast cancer.
The perspective concerning adult tissue macrophages being solely derived from bone marrow precursor cells have been recently abandoned. In fact, it has been shown that most tissue resident macrophages originated from yolk sac precursor cells18,19. On the other hand, macrophages found in pathogen associated inflammation mostly originate from bone marrow monocytes20. It has recently been show that most TAM sub-populations emerge from the Ly6C+ population of circulating mouse monocytes in grafted tumours21, primary mouse mammary tumours22 and in lung metastases23. Therefore, investigating the factors associated with monocyte recruitment to tumour tissues has utmost importance. Previous studies have shown that CAFs secrete large amounts of SDF-1. We found that CAF derived SDF-1 was crucial for monocyte recruitment, which underlines the key importance of the SDF-1/CXCR4 axis for progression of several cancers24. Previous studies have also shown that MCP-1 was able to induce infiltration of blood monocytes into CAF spheroids and to recruit monocytes into mammary tumours25. Even though CAF-induced monocyte migration decreased with MCP-1 inhibition in our study, this decrease was not as prominent as that seen with SDF-1 inhibition. This finding demonstrated that SDF-1 is more significant in CAF-induced monocyte chemotaxis than MCP-1.
Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor that is upregulated on activated T cells for the induction of immune tolerance26,27. Monoclonal antibodies targeting PD-1/PD-L1 pathway have been shown to be effective against several types of cancer28. In a very recent study, Gordon et al. have shown that PD-1 is also expressed by both mouse and human TAMs in addition to activated T cells29. They also characterized PD-1+ TAMs and showed that almost all PD-1+ TAMs express an M2-like surface profile29. In light of this important study, we investigated whether CAFs might have a role in inducing such immunosuppressive PD-1+ TAMs. The role of CAFs in the induction of PD-1 expression on TAMs have not been investigated before. We found that CAF-educated monocytes demonstrated high PD-1 expression as well as CD163 and CD206 expressions. Our findings demonstrate for the first time that CAFs are able to induce a PD-1+ TAM phenotype by themselves, even without the presence of tumour cells. In addition, our findings prove that CAFs are as potent as tumour cells in terms of inducing such PD-1 expressions (Fig. 3). Furthermore, we also demonstrated that PD-1+ TAMs are relevant for breast cancer in addition to colorectal cancer29. In line with these findings, we suggest that CAFs may recruit monocytes and induce these recruited monocytes to differentiate into PD-1 expressing M2-like macrophages, instead of M1 macrophages. Therefore, PD-1 axis might be crucial in CAF induced immune suppression in vivo in several types of cancer including breast and colorectal tumours.
In the current study, we also showed that CAF-educated monocytes exhibited increased expression of CD206 and CD163. Immune functions of CD206 (C-Type Mannose Receptor 1) has not yet been fully understood. It has been shown that the lack of CD206 results in the upregulation of pro-inflammatory cytokine production during endotoxemic lung inflammation in mice30 and increased serum levels of inflammatory proteins, suggesting that it may have a role in the resolution of inflammation by decreasing inflammatory molecules in the blood31. CAF mediated induction of higher expression of CD206, which has anti-inflammatory effects, on monocytes may also demonstrate another indirect mechanism of immune suppression by CAFs. CD163 is a haptoglobin-hemoglobin scavenger receptor and it correlates with known prognostic factors (e.g. poor differentiation (Grade 3), ER negativity and ductal type which are associated with bad prognosis)32. As one would expect, CAFs induced a very high CD163 expression on monocytes compared with NFs (Fig. 3). Interestingly, we found that breast cancer cells induced high CD163 and CD206 expressions on monocytes as well as MHC class II (HLA-DR) expression; whereas CAFs did not induce HLA-DR expression on monocytes. HLA-DR is well known to be associated with M1 macrophages. The induction of HLA-DR expression on monocytes by breast cancer cells may seem controversial; however, the study by Edin et al. has shown that colorectal cancer cells induce TAMs of a “mixed” M1/M2 phenotype, which in turn could contribute to a “good inflammatory response”33. Moreover, Helm et al. have demonstrated that HLA-DR and CD163 double positive cells were detectable by immunohistochemical stainings in pancreatic ductal adenocarcinoma tissues34. We propose that CAF-mediated down regulation of MHC class II expression on monocytes may demonstrate a mechanism of immune escape via decreased antigen presentation, in addition to confirming the notion that CAFs are not implicated in any types of “good inflammatory response”. On the other hand, it should also be noted that NF-educated monocytes expressed both CD14 and HLA-DR, which are associated with M1 macrophages3,4, more than CAF-educated monocytes. This finding shows that activated tumour stroma may have explicit functions in terms of macrophage polarization. In line with our findings, Zhang et al. demonstrated that the number of CD68+CD163+ macrophages was higher in breast cancer tissues than in normal breast tissues35.
Several studies showed that TAMs promote breast cancer invasion and metastasis by releasing a variety of cytokines36,37,38. In the current study, we demonstrated that CAF-educated monocytes increased breast cancer cell invasion as well as the expressions of EMT-related genes and vimentin protein significantly, while decreasing E-cadherin protein expression; in contrast to NF-educated monocytes. Our in vitro migration assay findings and gene/protein expression results display that CAF-educated monocytes enhance the motility of breast cancer cells. In a very recent study by Linde et al., CD206+ macrophages were shown to downregulate E-cadherin junctions in breast cancer cells39, which may facilitate EMT. Thus, our findings support the notion that CAFs promote EMT, invasion and metastasis40; via inducing M2 macrophages. We then investigated whether CAF-educated monocytes have immunosuppressive features. CAF-educated monocytes significantly suppressed T cell proliferation in contrast to control or NF-educated monocytes. CAFs were known to directly inhibit proliferation of T lymphocytes16,41. In the current study, we showed that CAFs also exert immunosuppressive effects, indirectly, by differentiating the monocytes into M2-like TAMs.
Activation status of M1/M2 macrophages in tumour tissues is transient, which gives them a functional plasticity42. Our results suggest that CAFs may re-direct M1 macrophages to M2-like macrophages in the tumour tissue. The differentiation of macrophages from anti-tumoural M1-like to pro-tumoural M2-like macrophages is a crucial event in the establishment of the tumour microenvironment. Thus, investigating the factors that drive the trans-differentiation of pro-inflammatory M1 macrophages to anti-inflammatory M2 macrophages in tumour tissues has great importance in terms of targeted therapies12. We observed that CAF-educated M1 macrophages showed increased secretion of IL-10 and decreased secretion of IL-12 in addition to phenotypic changes (i.e. increased expression of M2 markers). Even though our results demonstrated that CAF-educated M1 macrophages seem to display increased expressions of both CD163 and CD206, the increase in the expression of CD206 did not reach statistical significance (Fig. 7B). Given our results showing that CAF-educated monocytes show significantly increased expressions of both CD163 and CD206 (Fig. 3B), CD206 expression change of CAF-educated M1 macrophages seems interesting. In fact, our studies with human breast cancer tissue samples also demonstrated that higher number of CAFs is correlated with higher numbers of not only CD163+ but also CD206+ macrophages (Table 2). CD206 was reported to be more associated with M2a-like macrophages, while CD163 is prominent on the surface of M2c-like macrophages43,44. In addition, Mantovani et al. reported that M2a macrophages are associated with TH2 type immune responses and elimination of parasites, while M2c macrophages are more implicated in immunoregulation and tissue remodelling45. Therefore, CAFs may be inclined to polarize the M1 macrophages more into the M2c phenotype that is associated with immune suppression than M2a. Such a predilection seems reasonable considering tumours are known as wounds that do not heal and thus require a chronic wound healing/tissue remodelling process instead of an allergic response or killing of parasites. This might explain our results about CAF-educated M1 macrophages and our findings suggest that CAFs may be influencing M1/M2 trans-differentiation. It has been shown that IL-4, which is secreted from tumour cells and T lymphocytes46, as well as colony stimulating factor 1 (CSF-1) and granulocyte-macrophage colony-stimulating factor (GM-CSF), which are secreted from tumour cells47,48, take part in pro-tumoural differentiation of macrophages. In line with these studies, we suggest that CAFs may also prove to be important players in this re-polarization process.
Since the number of α-SMA+ fibroblasts was found to be significantly higher in the tumour stroma compared with that in benign breast tissue49 and the number of TAMs was higher in tumour stroma than in tumour nest50, we analysed the tumour stroma to evaluate both of these cells rather than the tumour nest. We found that the number of CD163+ TAMs significantly correlated with high tumour grade, high Ki-67 proliferation index and high tumour size. In line with such findings, CAF-educated monocytes were found to increase breast cancer cell proliferation in vitro (Fig. 9). The infiltration of CD163+ TAMs seemed to be the highest in triple negative, and the lowest in ER+PR+ breast cancer samples (Fig. 8), although such findings were not statistically significant.
The copresence of CAFs and TAMs inside a tumour was considered to be a potential prognostic feature in colorectal cancer patients51. In the current study, we showed that there exists a significant correlation between the number of TAMs and the CAF grade in breast cancer. It was recently reported that CAF-derived Chitinase 3-like 1, which is implicated in inflammatory disorders, contributed to tumour growth in breast cancer and this contribution is accompanied by a high infiltration of M2-polarized macrophages and TH2 type immune responses52. Therefore, our finding of increased infiltration of breast tumour tissues with TAMs might be a direct result of the presence of high number of CAFs in those tumours; since we also demonstrated that CAFs recruit monocytes and induce M2 type polarization.
In this study, we examined the relationship between cancer-associated fibroblasts (CAFs) and monocytes/macrophages in breast cancer using human ex vivo cellular systems and tissues samples obtained from breast cancer patients as well as in vitro cell lines. Even though our studies were not performed using in vivo systems, our results demonstrate that CAFs promote monocyte migration and enhance their differentiation to M2-like macrophages; based on phenotype, cytokine and functional features. In addition, our studies with human breast cancer patient tissue microarrays (TMAs) showed some translational promise. Future in vivo experiments will shed further light on such new mechanistic insights and provide broader implications, as such systems would simulate all the elements of the tumour microenvironment, as well as demonstrating the effects of cell-to-cell contact in addition to the cross-talk mediated via soluble factors demonstrated in our study. Accordingly, in vivo experiments in severe combined immunodeficiency (SCID) mice can be used to prove that human monocytes co-injected s.c. with tumour cells acquire a stronger protumoural effect if preconditioned with CAFs in contrast to NFs.
Materials and Methods
Isolation of fibroblasts from normal and cancerous breast tissue
Normal breast tissues were obtained from 3 patients undergoing reduction mammoplasty and breast cancer tissues were obtained from 4 patients undergoing therapeutic mastectomy. All fibroblasts were isolated using a previously described protocol41,53 that utilizes Collagenase I (1 mg/mL) and Hyaluronidase (125 U/mL) enzymes followed by differential sedimentation and plating. Enzymatically digested tissues were then cultured in high serum media conditions which select for fibroblast growth (Dulbecco’s Modified Eagle’s medium [DMEM] supplemented with 10% foetal bovine serum at 37 C, 5% CO2). All human breast tissues for all of the experiments were obtained in accordance with the laws and institutional guidelines, as approved by the institutional review board of Hacettepe University (Approval numbers: GO 16/64 - 20 and GO 17/380 - 31). Informed consent was obtained from all participants.
Characterization of fibroblasts with immunocytochemistry
Characterizations of fibroblasts were performed by immunocytochemistry stainings with vimentin, pan-cytokeratin and α-SMA according to the manufacturer’s instructions. Cells (7 × 104 cells/300 µL in each well) were cultured in eight well chamber slides and immunocytochemical / morphological analyses were performed when the cells reached a surface confluency of >80%. A biotin/streptavidin/horseradish peroxidase detection system was utilized and binding of the antibody was demonstrated with diaminobenzidine (DAB) substrate. The images were captured by Olympus BX50 microscope.
Preparation of conditioned medium (CM)
CMs were obtained from CAFs, NFs and MDA-MB-231 breast cancer cells. When the aforementioned cells reached to a confluency of >80%, they were serum starved. After 48 h, CMs were collected from cell supernatants and clarified by centrifugation.
Isolation and culture of peripheral CD14+ monocytes
PBMCs were isolated from healthy volunteers’ peripheral blood using density gradient separation with Histopaque-1077. Separation of CD14+ monocytes from PBMCs was accomplished by using a magnetic bead based positive selection protocol with a purity of >95%. CD14+ monocytes were cultured alone as control monocytes or with CMs from CAFs, NFs or MDA-MB-231 breast cancer cells (CM:RPMI, 1:1) for 7-days.
Phenotypical analyses with flow cytometry
CD14+ PBMCs isolated from healthy donors were cultured with CMs from NFs, CAFs, MDA-MB-231 breast cancer cells as well as in standard medium for 7 days, then analysed using flow cytometry. M1 macrophages were cultured with CMs from CAFs or MDA-MB-231 cells for 48 hours, then analysed by flow cytometry.
Cultured monocytes or macrophages were detached using Accutase cell detachment solution, according to the manufacturer’s instructions. Cells were stained with antibodies against CD206, CD163, HLA-DR, CD14, and PD-1. All antibodies were conjugated to Phycoerythrin (PE) or Fluorescein isothiocyanate (FITC). Respective isotype-matched antibody controls were used as negative controls.
Isolation of peripheral blood CD4+ T-cells
PBMCs were isolated from healthy volunteers’ peripheral blood using density gradient separation with Histopaque-1077. Separation of CD4+ T-cells from PBMCs was accomplished by using a magnetic bead based negative selection protocol with a purity of >95%. CD4+ T-cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% foetal calf serum, 2.1 mM L-glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin at 37 °C, 5% CO2.
CFSE proliferation assays
In order to assess the effects of CAF-, NF- and MDA-MB-231-educated monocytes on CD4+ T lymphocytes, we performed functional analyses with flow cytometry. Carboxyfluorescein succinimidyl ester (CFSE) labelled CD4+ T-cells were activated by CD3/CD28 magnetic beads (except the negative control group). Activated T-cells were cultured with either control monocytes or with monocytes that had been cultured with CMs from CAFs, NFs or MDA-MB-231 cells for 7 days. After 96 hours, proliferation of CFSE labelled CD4+ T cells was evaluated by flow cytometry.
Evaluation of cell migration
In order to evaluate the effects of CAFs, NFs, or MDA-MB-231 cells on monocyte recruitment, we performed in vitro migration assays. Monocyte cells were seeded into the upper compartment in serum-free medium (5 × 104 cells in 200 µl). The 5 µm Transwell chambers were placed into 24-well culture wells containing CMs from CAFs, NFs, or MDA-MB-231 cells. After 5 h incubation, non-migrated cells were removed by cotton swab. Migrated cells were fixed by methanol and stained with Crystal violet. Migrated cells were counted in five different fields of polycarbonate filter under a microscope (magnification x100).
Evaluation of EMT-related protein expressions by Western Blot
MDA-MB-231 breast cancer cells were cultured for 24 hours prior to CM treatments. The cells were then treated with CMs from NF-, CAF-, MDA-MB-231- educated monocytes or from control monocytes for 48 hours. At the end of this period, cells were lysed in RIPA (Thermo Fisher Scientific, Waltham, MA, USA) lysis buffer supplemented with protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA, USA). E-cadherin (primary antibody: Cell Signaling Technology, Danvers, MA, USA; #3195) and vimentin (primary antibody: Cell Signaling Technology, Danvers, MA, USA; 5741) protein expressions in samples were examined by the Western blot method. GAPDH (primay antibody: Cell Signaling Technology, Danvers, MA, USA, #5174) was used as the Western blot loading control. The membranes were visualized by chemiluminescence (ECL) and densitometry analyses of the protein bands were performed.
Evaluation of EMT-related gene expressions by quantitative real-time PCR
MDA-MB-231 breast cancer cells were cultured for 24 hours prior to CM treatments. The cells were then treated with CMs from NF-, CAF-, MDA-MB-231- educated monocytes or from control monocytes for 48 hours. At the end of this period, RNA isolation from the cells was performed according to the Zymo Quick-RNA Miniprep Kit protocol. Complementary DNA was synthesized with Thermo Scientific RevertAid First Strand cDNA Kit according to the manufacturer’s instructions. Real-time qPCR was performed using LightCycler FastStart DNA Master SYBR Green (Roche, Basel, Switzerland). The qPCR data were analysed using the Livak model (2−ΔΔCt). Snail (Snail_reverse 5′-CTGCTGGAAGGTAAACTCTGGA-3′, Snail_forward 5′-CGAGTGGTTCTTCTGCGCTA-3′), Slug (Slug_reverse 5′-TTCTCCCCCGTGTGAGTTCTAA-3′, Slug_forward 5′-CACTGCGATGCCCAGTCTA-3′), and Twist (Twist_reverse 5′-CCCACGCCCTGTTTCTTTGA-3′, Twist_forward 5′-GCCGGAGACCTAGATGTCATT-3′) gene expressions were evaluated. β -actin was used as the reference gene.
Evaluation of cell invasion
MDA-MB-231 breast cancer cell invasion was evaluated by using Transwell inserts in vitro. Monocytes were differentiated for 7 days using CMs from NF, CAF or MDA-MB-231 cells as well as in standard medium. All the differentiated monocytes were then serum starved for 48 h and corresponding supernatants were then collected. MDA-MB-231 cells in serum-free medium were seeded into upper compartments of Transwell inserts which were pre-coated with Matrigel (5 × 104 cells in 200 µl). The lower compartment contained the aforementioned supernatants, which were obtained from monocytes. After 24 hours, non-migrated cells were removed by cotton swab. Migrated cells were fixed by methanol and stained with Crystal violet. Migrated cells were counted in five different fields of polycarbonate filter under a microscope (magnification x200).
Induction of M1/M2 polarization of macrophages
CD14+ monocytes were cultured in medium containing macrophage colony-stimulating factor (M-CSF) (50 ng/ml) for 7 days to obtain M0 macrophages. In order to acquire M1 macrophages, M0 macrophages were further cultured in medium containing interferon gamma (IFNγ) (100 ng/ml) and lipopolysaccharides (LPS) (10 ng/ml) for 2 more days. On the other hand, M0 macrophages were further cultured in medium containing IL-4 (20 ng/ml) for 2 more days in order to obtain M2 macrophages.
Assessment of soluble factors by ELISA
In order to evaluate the levels of IL-12 and IL-10 cytokines in the culture supernatants of M1 and M2 macrophages, we performed enzyme-linked immunosorbent assays (ELISA). We cultured M1 or M2 macrophages alone (as negative control) or with CMs from CAFs, or MDA-MB-231 breast cancer cells for 2 days. After this period, the cells were further cultured for additional 2 days in serum-free medium. Culture supernatants were stored at −80 °C until the assays were performed.
Measurement of cell proliferation by MTT assay
MDA-MB-231 breast cancer cell proliferation was evaluated via MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay. MDA-MB-231 cells were seeded in 96-well plates. After about a day of incubation, CMs obtained from CAF- or NF-educated-monocytes were added to the wells and MDA-MB-231 cell proliferations were analysed after an additional 48 hours (72 hours in total) by adding 25 μl MTT reagent (final concentration: 1 mg/ml) in each well. 4 hours after adding the MTT reagent, the precipitate was solubilized by 80 μl detergent reagent. The plates were then left overnight in the dark and the absorbances were recorded at 570 nm.
Real-time and label-free analysis of MDA-MB-231 cells with the xCELLigence system
In order to assess the real-time effects of CAF- and NF-educated monocytes on MDA-MB-231 breast cancer cell proliferation, we performed functional analyses with the RTCA xCELLigence System (ACEA, San Diego, CA, USA). This system utilizes gold biosensor microelectrodes to measure electrical impedance. The background impedance of the microelectrodes were first measured with cell culture medium. Then, MDA-MB-231 breast cancer cells were added to each well of the E-plate. After about a day of incubation, CMs obtained from CAF- or NF-educated-monocytes were added to the wells and the cell indices were measured by electrical impedance over an additional period of 48 hours (72 hours in total).
Tissue samples and immunohistochemical stainings
A total of 50 human invasive breast cancer tissue samples were investigated. Patients who had received preoperative/adjuvant chemotherapy or radiotherapy were excluded. Clinical and pathological variables including age, tumour grade and size, lymph node involvement, Ki-67 staining as well as ER, PR and HER2 status were evaluated.
Formalin-fixed paraffin-embedded tumour samples were used for tissue microarrays (TMAs). Blocks were made utilizing a 4.0 mm tissue cylinder through a histologically representative area of each donor tumour block. From each donor block, 1–2 cores were cut and 8 TMA blocks were prepared. Immunohistochemical stainings for CD163 (Biocare, Clone 10D6, 10 min EDTA, 1:100), CD206 (Abcam, ab64693, 20 min EDTA, 1:200) and α-SMA (Neomarkers, Clone 1A4, 1:1000) as well as Haematoxylin and Eosin (H&E) were performed on the 4-μm thick sections taken from the tissue microarrays using Leica Bond Max III Autostainer, following manufacturer’s instructions. Concentrations and antigen retrieval methods were optimized for each antibody using appropriate positive and negative controls.
TAM and CAF grade evaluations
All tissue microarray slides stained with anti-CD163 or anti-CD206 were analysed to identify areas with the highest levels of TAM infiltration. For each case, three hot spots in the tumour stroma (40x objective) were selected for counting TAMs. The median values of CD163+ or CD206+ macrophage numbers in stroma within the areas were used to categorize the patients into high and low grade groups. The intensity of CAFs (α-SMA positive spindle-shaped fibroblasts) was classified into 2 grades, using a modification of a method previously described54: negative to scanty (low grade) or abundant (high grade) in a blinded analysis performed by 2 of the authors (K.K., and B.G.Y.).
The Mann-Whitney U test, Student’s t-test, chi-squared test, and Fisher’s exact test were used to examine differences in continuous and categorical variables. A 5% type-I error level was used to infer statistical significance. All statistical analyses were carried out using IBM SPSS Statistics for Windows Software version 23.
Our results propose that CAFs recruit monocytes and induce TAMs which might be suppressing the immune system via the PD-1 axis. We herein demonstrated that CAFs play pivotal roles in sculpturing the tumour microenvironment in breast cancer, and therapeutic strategies to reverse the CAF-mediated immunosuppressive microenvironment should be taken into consideration in order to increase the effectiveness of conventional therapies as well as immunotherapies against breast cancer.
All data generated or analysed during this study are included in this published article.
Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539–545, https://doi.org/10.1016/S0140-6736(00)04046-0 (2001).
Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4, 71–78, https://doi.org/10.1038/nrc1256 (2004).
Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nature reviews. Immunology 8, 958–969, https://doi.org/10.1038/nri2448 (2008).
Ambarus, C. A. et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. Journal of immunological methods 375, 196–206, https://doi.org/10.1016/j.jim.2011.10.013 (2012).
Porcheray, F. et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142, 481–489, https://doi.org/10.1111/j.1365-2249.2005.02934.x (2005).
Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14–20, https://doi.org/10.1016/j.immuni.2014.06.008 (2014).
Lewis, C. E., Leek, R., Harris, A. & McGee, J. O. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57, 747–751 (1995).
Bingle, L., Brown, N. J. & Lewis, C. E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. The Journal of pathology 196, 254–265, https://doi.org/10.1002/path.1027 (2002).
Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49–61, https://doi.org/10.1016/j.immuni.2014.06.010 (2014).
Sica, A., Schioppa, T., Mantovani, A. & Allavena, P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. European journal of cancer (Oxford, England: 1990) 42, 717–727, https://doi.org/10.1016/j.ejca.2006.01.003 (2006).
Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. The Journal of clinical investigation 122, 787–795, https://doi.org/10.1172/JCI59643 (2012).
Balkwill, F. R. & Mantovani, A. Cancer-related inflammation: common themes and therapeutic opportunities. Seminars in cancer biology 22, 33–40, https://doi.org/10.1016/j.semcancer.2011.12.005 (2012).
Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650–1659, https://doi.org/10.1056/NEJM198612253152606 (1986).
De Wever, O., Demetter, P., Mareel, M. & Bracke, M. Stromal myofibroblasts are drivers of invasive cancer growth. International journal of cancer 123, 2229–2238, https://doi.org/10.1002/ijc.23925 (2008).
Orimo, A. & Weinberg, R. A. Heterogeneity of stromal fibroblasts in tumors. Cancer biology & therapy 6, 618–619 (2007).
Harper, J. & Sainson, R. C. Regulation of the anti-tumour immune response by cancer-associated fibroblasts. Seminars in cancer biology 25, 69–77, https://doi.org/10.1016/j.semcancer.2013.12.005 (2014).
Dicle, G. et al. The effects of Cancer Associated Fibroblasts on mechanisms of immune evasion in a rat chemical mammary carcinoma model. Frontiers in Immunology 4, https://doi.org/10.3389/conf.fimmu.2013.02.01132 (2013).
Bertrand, J. Y. et al. Three pathways to mature macrophages in the early mouse yolk sac. Blood 106, 3004–3011, https://doi.org/10.1182/blood-2005-02-0461 (2005).
Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90, https://doi.org/10.1126/science.1219179 (2012).
Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445–455, https://doi.org/10.1038/nature12034 (2013).
Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer research 70, 5728–5739, https://doi.org/10.1158/0008-5472.CAN-09-4672 (2010).
Franklin, R. A. et al. The cellular and molecular origin of tumor-associated macrophages. Science 344, 921–925, https://doi.org/10.1126/science.1252510 (2014).
Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222–225, https://doi.org/10.1038/nature10138 (2011).
Teicher, B. A. & Fricker, S. P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 16, 2927–2931, https://doi.org/10.1158/1078-0432.CCR-09-2329 (2010).
Ksiazkiewicz, M. et al. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts. Immunobiology 215, 737–747, https://doi.org/10.1016/j.imbio.2010.05.019 (2010).
Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141–151 (1999).
Freeman, G. J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. The Journal of experimental medicine 192, 1027–1034 (2000).
Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366, 2443–2454, https://doi.org/10.1056/NEJMoa1200690 (2012).
Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495–499, https://doi.org/10.1038/nature22396 (2017).
Kambara, K. et al. In vivo depletion of CD206+ M2 macrophages exaggerates lung injury in endotoxemic mice. The American journal of pathology 185, 162–171, https://doi.org/10.1016/j.ajpath.2014.09.005 (2015).
Lee, S. J. et al. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295, 1898–1901, https://doi.org/10.1126/science.1069540 (2002).
Sousa, S. et al. Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res 17, 101, https://doi.org/10.1186/s13058-015-0621-0 (2015).
Edin, S., Wikberg, M. L., Rutegard, J., Oldenborg, P. A. & Palmqvist, R. Phenotypic skewing of macrophages in vitro by secreted factors from colorectal cancer cells. PLoS One 8, e74982, https://doi.org/10.1371/journal.pone.0074982 (2013).
Helm, O. et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS One 9, e94357, https://doi.org/10.1371/journal.pone.0094357 (2014).
Zhang, B. et al. Increased circulating M2-like monocytes in patients with breast cancer. Tumour Biol 39, 1010428317711571, https://doi.org/10.1177/1010428317711571 (2017).
Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266, https://doi.org/10.1016/j.cell.2006.01.007 (2006).
Gocheva, V. et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes & development 24, 241–255, https://doi.org/10.1101/gad.1874010 (2010).
Pittet, M. J. Behavior of immune players in the tumor microenvironment. Current opinion in oncology 21, 53–59, https://doi.org/10.1097/CCO.0b013e32831bc38a (2009).
Linde, N. et al. Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun 9, 21, https://doi.org/10.1038/s41467-017-02481-5 (2018).
Karagiannis, G. S. et al. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res 10, 1403–1418, https://doi.org/10.1158/1541-7786.MCR-12-0307 (2012).
Gunaydin, G., Kesikli, S. A. & Guc, D. Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset. Oncoimmunology 4, e1034918, https://doi.org/10.1080/2162402X.2015.1034918 (2015).
Zheng, X. et al. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. Oncotarget 8, 48436–48452, https://doi.org/10.18632/oncotarget.17061 (2017).
Olmes, G. et al. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis. Arthritis Res Ther 18, 90, https://doi.org/10.1186/s13075-016-0989-y (2016).
Ohlsson, S. M. et al. Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization. Clin Immunol 152, 10–19, https://doi.org/10.1016/j.clim.2014.02.016 (2014).
Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677–686, https://doi.org/10.1016/j.it.2004.09.015 (2004).
Coussens, L. M., Zitvogel, L. & Palucka, A. K. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339, 286–291, https://doi.org/10.1126/science.1232227 (2013).
Lin, E. Y., Gouon-Evans, V., Nguyen, A. V. & Pollard, J. W. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. Journal of mammary gland biology and neoplasia 7, 147–162 (2002).
Su, S. et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer cell 25, 605–620, https://doi.org/10.1016/j.ccr.2014.03.021 (2014).
Amornsupak, K. et al. High ASMA(+) Fibroblasts and Low Cytoplasmic HMGB1(+) Breast Cancer Cells Predict Poor Prognosis. Clin Breast Cancer 17, 441–452 e442, https://doi.org/10.1016/j.clbc.2017.04.007 (2017).
Medrek, C., Ponten, F., Jirstrom, K. & Leandersson, K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12, 306, https://doi.org/10.1186/1471-2407-12-306 (2012).
Herrera, M. et al. Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. Cancer Sci 104, 437–444, https://doi.org/10.1111/cas.12096 (2013).
Cohen, N. et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene 36, 4457–4468, https://doi.org/10.1038/onc.2017.65 (2017).
Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348, https://doi.org/10.1016/j.cell.2005.02.034 (2005).
Kellermann, M. G. et al. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 44, 509–517, https://doi.org/10.1016/j.oraloncology.2007.07.001 (2008).
This study was supported by Hacettepe University Scientific Research Projects Coordination Unit.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gok Yavuz, B., Gunaydin, G., Gedik, M.E. et al. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs. Sci Rep 9, 3172 (2019). https://doi.org/10.1038/s41598-019-39553-z
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Molecular Cancer (2021)
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
BMC Cancer (2021)
The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer
Cancer Cell International (2021)
Journal of Translational Medicine (2021)
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry
Nature Communications (2021)